Title : Efficacy and safety of sorafenib plus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.

Pub. Date : 2021 Dec

PMID : 34583091






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Subgroup analysis of OS showed that patients with Child-Pugh score B (HR: 0.30; 95% CI 0.13 to 0.72; P < 0.05) and AFP <400 ng/ml (HR: 0.72; 95% CI 0.52 to 0.99; P < 0.05) were associated with significantly improved survival in the Sorafenib + HAIC group. Sorafenib alpha fetoprotein Homo sapiens
2 CONCLUSIONS: Patients with Child-Pugh score B and AFP <400 ng/ml may be benefited most from Sorafenib + HAIC combination therapy. Sorafenib alpha fetoprotein Homo sapiens